• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Animal & Veterinary

  • Print
  • Share
  • E-mail

NEW ANIMAL DRUG APPROVALS - May/June 1999

FDA Veterinarian Newsletter May/June 1999 Volume XIV, No III

CompanyGeneric and (Brand) NamesIndicationsRoutes/Remarks
Alharma Inc.
(NADA 141-060)
Decoquinate medicated powderCalves (ruminating and non-ruminating, including veal). For prevention of coccidiosis.ORAL: The powder is added to whole milk and fed to calves. The0.8 percent medicated powder in milk is to prevent coccidiosis caused by Eimeria bovis and E. zurni. In addition, an ADI for decoquinate is codified. Federal Register: 3/2/99
Elanco Animal Health, a Division of Eli Lilly and Co. (NADA 141-110)Monensin and VirginiamycinTurkeys. For the prevention of coccidiosis caused by Eimeria meleagrimitis, E. adenoeides, and E. gallopavonis, and for increased rate of weight gain, and improved feed efficiency.MEDICATED FEED: Combining approved monensin and virginiamycin Type A medicated articles to make a combination drug Type C medicated growing turkey feed containing 54 to 90 g/t monensin with 10 to 20 g/t of virginiamycin. For growing turkeys only. Do not allow horses, other equines, mature turkeys or guinea fowl access to feed containing monensin. Federal Register: 03/17/99
Merial Ltd. (NADA 141-097)Ivermectin
(Ivomec®) and Bacitracin methylene disalicylate (BMD®)
Swine. For use as antiparasitics, antibacterials, and growth promotants.MEDICATED FEED: Combining approved ivermectin and BMD Type A medicated articles to make Type B and C medicated swine feeds. The Type C medicated feeds contain 1.8g of ivermectin and 10, 30, or 250g of BMD® per ton for feeding to growing and finishing swine and pregnant sows. Federal Register: 03/18/99